Study of the effects of venlafaxine for the brain plasticity of patients with generalized anxiety disorder

Trial Profile

Study of the effects of venlafaxine for the brain plasticity of patients with generalized anxiety disorder

Completed
Phase of Trial: Phase III/IV

Latest Information Update: 04 May 2016

At a glance

  • Drugs Venlafaxine (Primary)
  • Indications Generalised anxiety disorder
  • Focus Pharmacodynamics
  • Most Recent Events

    • 02 May 2016 Status changed from not yet recruiting to completed, as reported by Chinese Clinical Trial Registry.
    • 29 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top